[go: up one dir, main page]

WO2001009337A3 - Moraxella catarrhalis antigens basb122 and basb124 - Google Patents

Moraxella catarrhalis antigens basb122 and basb124 Download PDF

Info

Publication number
WO2001009337A3
WO2001009337A3 PCT/EP2000/007365 EP0007365W WO0109337A3 WO 2001009337 A3 WO2001009337 A3 WO 2001009337A3 EP 0007365 W EP0007365 W EP 0007365W WO 0109337 A3 WO0109337 A3 WO 0109337A3
Authority
WO
WIPO (PCT)
Prior art keywords
basb124
basb122
moraxella catarrhalis
catarrhalis antigens
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2000/007365
Other languages
French (fr)
Other versions
WO2001009337A2 (en
Inventor
Joelle Thonnard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9918036.6A external-priority patent/GB9918036D0/en
Priority claimed from GBGB9918034.1A external-priority patent/GB9918034D0/en
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Priority to EP00953120A priority Critical patent/EP1204749A2/en
Priority to AU65683/00A priority patent/AU6568300A/en
Priority to CA002378168A priority patent/CA2378168A1/en
Publication of WO2001009337A2 publication Critical patent/WO2001009337A2/en
Publication of WO2001009337A3 publication Critical patent/WO2001009337A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The invention provides BASB122 and BASB124 polypeptides and polynucleotides encoding BASB122 and BASB124 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.
PCT/EP2000/007365 1999-07-30 2000-07-31 Moraxella catarrhalis antigens basb122 and basb124 Ceased WO2001009337A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP00953120A EP1204749A2 (en) 1999-07-30 2000-07-31 Moraxella catarrhalis antigens basb122 and basb124
AU65683/00A AU6568300A (en) 1999-07-30 2000-07-31 Novel compounds
CA002378168A CA2378168A1 (en) 1999-07-30 2000-07-31 Moraxella catarrhalis antigens basb122 and basb124

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9918036.6A GB9918036D0 (en) 1999-07-30 1999-07-30 Novel compounds
GB9918036.6 1999-07-30
GB9918034.1 1999-07-30
GBGB9918034.1A GB9918034D0 (en) 1999-07-30 1999-07-30 Novel compounds

Publications (2)

Publication Number Publication Date
WO2001009337A2 WO2001009337A2 (en) 2001-02-08
WO2001009337A3 true WO2001009337A3 (en) 2001-06-14

Family

ID=26315813

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2000/007365 Ceased WO2001009337A2 (en) 1999-07-30 2000-07-31 Moraxella catarrhalis antigens basb122 and basb124

Country Status (4)

Country Link
EP (1) EP1204749A2 (en)
AU (1) AU6568300A (en)
CA (1) CA2378168A1 (en)
WO (1) WO2001009337A2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997032980A1 (en) * 1996-03-08 1997-09-12 Connaught Laboratories Limited Transferrin receptor genes of moraxella

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1824101A (en) * 1999-06-18 2001-01-09 Elitra Pharmaceuticals, Inc. Nucleotide sequences of moraxella catarrhalis genome

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997032980A1 (en) * 1996-03-08 1997-09-12 Connaught Laboratories Limited Transferrin receptor genes of moraxella

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL - EMHUM1 21 June 1999 (1999-06-21), BRUCE, D. ET AL: "Homo sapiens chromosome 16 clone RPCI-11_523L20, complete sequence.", XP002157349 *

Also Published As

Publication number Publication date
AU6568300A (en) 2001-02-19
CA2378168A1 (en) 2001-02-08
EP1204749A2 (en) 2002-05-15
WO2001009337A2 (en) 2001-02-08

Similar Documents

Publication Publication Date Title
WO1999058562A3 (en) Novel compounds
WO1999061620A3 (en) Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
WO1999057277A3 (en) Basb019 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
WO1999058684A3 (en) Compounds from moraxella catarrhalis
WO1999064602A3 (en) Moraxella catarrhalis polynucleotides and polypeptides
WO1999063093A3 (en) Basb027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
WO2000071724A3 (en) Novel compounds from moraxella catarrhalis
HK1047943A1 (en) Moraxella cattarrhalis basb114 antigens and uses thereof
WO2002034768A3 (en) Polypeptides and polynucleodides from haemophilus influenzae and their use
WO1999064448A3 (en) Moraxella catarrhalis pilq proteins
WO2001009331A3 (en) Moraxella catarrhalis antigen basb125
WO2001009339A3 (en) Moraxella catarrhalis antigen basb117
WO2001009332A3 (en) Immunogenic polypeptides derived from moraxella catarrhalis and uses thereof
HK1047956A1 (en) Basb118 polypeptide and polynucleotide from moraxella catarrhalis
WO2002088361A3 (en) Haemophilus influenzae antigens
WO2001009337A3 (en) Moraxella catarrhalis antigens basb122 and basb124
WO1999058682A3 (en) Compounds from moraxella catarrhalis
WO2001009330A3 (en) Moraxella catarrhalis antigen basb121
WO2001009335A3 (en) Moraxella catarrhalis antigen basb120
WO2002030960A3 (en) Polypeptide from haemophilus influenza
WO2001009333A3 (en) Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof
WO2000042191A3 (en) Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
AU6988700A (en) Basb119 polypeptide and polynucleotide from moraxella catarrhalis
WO1999058685A3 (en) Basb028 polypeptides and polynucleotides encoding therefor from moraxella catarrhalis
WO2002034772A3 (en) Novel compounds

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2000953120

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2378168

Country of ref document: CA

Ref document number: 10048197

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2000953120

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2000953120

Country of ref document: EP